These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 24775564)

  • 1. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
    Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
    Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidithiodiketopiperazines block the interaction between hypoxia-inducible factor-1alpha (HIF-1alpha) and p300 by a zinc ejection mechanism.
    Cook KM; Hilton ST; Mecinovic J; Motherwell WB; Figg WD; Schofield CJ
    J Biol Chem; 2009 Sep; 284(39):26831-8. PubMed ID: 19589782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-Regulation of ENO1 by HIF-1α in Retinal Pigment Epithelial Cells after Hypoxic Challenge Is Not Involved in the Regulation of VEGF Secretion.
    Zheng F; Jang WC; Fung FK; Lo AC; Wong IY
    PLoS One; 2016; 11(2):e0147961. PubMed ID: 26882120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma.
    Viziteu E; Grandmougin C; Goldschmidt H; Seckinger A; Hose D; Klein B; Moreaux J
    Br J Cancer; 2016 Mar; 114(5):519-23. PubMed ID: 26867162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Biological Effects of Marine Pyrroloiminoquinone Alkaloids: Potential Inhibitors of the HIF-1α/p300 Interaction.
    Goey AK; Chau CH; Sissung TM; Cook KM; Venzon DJ; Castro A; Ransom TR; Henrich CJ; McKee TC; McMahon JB; Grkovic T; Cadelis MM; Copp BR; Gustafson KR; Figg WD
    J Nat Prod; 2016 May; 79(5):1267-75. PubMed ID: 27140429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Evaluation of Discorhabdins in Antiangiogenic and Antitumor Models.
    Harris EM; Strope JD; Beedie SL; Huang PA; Goey AKL; Cook KM; Schofield CJ; Chau CH; Cadelis MM; Copp BR; Gustafson KR; Figg WD
    Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 30029505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual targeting of the androgen receptor and hypoxia-inducible factor 1α pathways synergistically inhibits castration-resistant prostate cancer cells.
    Fernandez EV; Reece KM; Ley AM; Troutman SM; Sissung TM; Price DK; Chau CH; Figg WD
    Mol Pharmacol; 2015 Jun; 87(6):1006-12. PubMed ID: 25829060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of a novel screening assay for inhibitors targeting HIF-1alpha and P300 interaction].
    Lai FF; Niu F; Yang HZ; Zhou WQ; Chen XG
    Yao Xue Xue Bao; 2014 Jun; 49(6):849-53. PubMed ID: 25212031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menadione and ethacrynic acid inhibit the hypoxia-inducible factor (HIF) pathway by disrupting HIF-1α interaction with p300.
    Na YR; Han KC; Park H; Yang EG
    Biochem Biophys Res Commun; 2013 May; 434(4):879-84. PubMed ID: 23618863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arylsulfonamide KCN1 inhibits in vivo glioma growth and interferes with HIF signaling by disrupting HIF-1α interaction with cofactors p300/CBP.
    Yin S; Kaluz S; Devi NS; Jabbar AA; de Noronha RG; Mun J; Zhang Z; Boreddy PR; Wang W; Wang Z; Abbruscato T; Chen Z; Olson JJ; Zhang R; Goodman MM; Nicolaou KC; Van Meir EG
    Clin Cancer Res; 2012 Dec; 18(24):6623-33. PubMed ID: 22923450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AGR2-induced glucose metabolism facilitated the progression of endometrial carcinoma via enhancing the MUC1/HIF-1α pathway.
    Gong W; Ekmu B; Wang X; Lu Y; Wan L
    Hum Cell; 2020 Jul; 33(3):790-800. PubMed ID: 32304027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIF-1alpha, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas.
    Gray MJ; Zhang J; Ellis LM; Semenza GL; Evans DB; Watowich SS; Gallick GE
    Oncogene; 2005 Apr; 24(19):3110-20. PubMed ID: 15735682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of p300 and cyclic adenosine monophosphate response element binding protein in high glucose-induced hypoxia-inducible factor 1α inactivation under hypoxic conditions.
    Ding L; Yang M; Zhao T; Lv G
    J Diabetes Investig; 2017 May; 8(3):277-285. PubMed ID: 27808477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS
    BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visualization of hypoxia-inducible factor 1α-p300 interactions in live cells by fluorescence resonance energy transfer.
    Kim SY; Lee MJ; Na YR; Kim SY; Yang EG
    J Cell Biochem; 2014 Feb; 115(2):271-80. PubMed ID: 23966271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
    Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
    Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition.
    Dai M; Miao ZH; Ren X; Tong LJ; Yang N; Li T; Lin LP; Shen YM; Ding J
    J Cell Mol Med; 2010 Sep; 14(9):2281-91. PubMed ID: 19538463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
    Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
    BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.